NRC Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for NRC Health (NRC).

Price Target Range — 2 Quarters

Analyst Consensus — 1 Analysts

1S.Buy

Consensus RatingMarket Outperform# Analysts1Avg. Consensus PT$26Upside to Avg. PT+18.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 29, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$23→$26
Jun 22, 2026	Citizens	Constantine Davides	Initiate	Market Outperform	$23

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

Citizens analyst Constantine Davides maintains NRC Health (NASDAQ:NRC) with a Market Outperform and raises the price target from $23 to $26.

Benzinga Newsdesk

PRO
Citizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23

Citizens analyst Constantine Davides initiates coverage on NRC Health (NASDAQ:NRC) with a Market Outperform rating and announces Price Target of $23.

Benzinga Newsdesk

UPDATE: Wunderlich Securities Reiterates Buy, Raises PT to $43 on Scana

Benzinga

Williams Capital Research Comments on SCANA Corporation

Benzinga

Rodman & Renshaw Maintains Market Outperform, PT

Benzinga

Dahlman Rose Reaffirms Uranerz Energy Buy, $5 PT

Benzinga

NRC Health

ニュース

パートナーシップ

ベンジンガ・グローバル

NRC Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

PRO
Citizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23

UPDATE: Wunderlich Securities Reiterates Buy, Raises PT to $43 on Scana

Williams Capital Research Comments on SCANA Corporation

Rodman & Renshaw Maintains Market Outperform, PT

Dahlman Rose Reaffirms Uranerz Energy Buy, $5 PT

People Also Watch

People Also Watch

NRC Health

ニュース

パートナーシップ

ベンジンガ・グローバル

NRC Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCitizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

PROCitizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23

UPDATE: Wunderlich Securities Reiterates Buy, Raises PT to $43 on Scana

Williams Capital Research Comments on SCANA Corporation

Rodman & Renshaw Maintains Market Outperform, PT

Dahlman Rose Reaffirms Uranerz Energy Buy, $5 PT

People Also Watch

People Also Watch

PRO
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

PRO
Citizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23